Products selection and Positioning is made based on the potential and the scope for a particular molecule, hence a mix of the time tested products and some new molecules are in its portfolio. Apart from the above products already launched, we have the approval from the regulatory authorities and will launch more than 10 products in a phased manner.
Poised for a Quantum growth in the Dermatology segment as we strictly adhere to global market standards and we are steadily capturing the favorable market conditions to expand further. The Pediatric segment, as usual, is booming and as a strategy we have entered this area to bridge a gap in some Therapeutic segments.
